Details for Patent: 12,064,442
✉ Email this page to a colleague
Which drugs does patent 12,064,442 protect, and when does it expire?
Patent 12,064,442 protects RYALTRIS and is included in one NDA.
This patent has ninety patent family members in thirty-three countries.
Drugs Protected by US Patent 12,064,442
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Speclt | RYALTRIS | mometasone furoate; olopatadine hydrochloride | SPRAY, METERED;NASAL | 211746-001 | Jan 13, 2022 | RX | Yes | Yes | 12,064,442 | ⤷ Subscribe | TREATMENT OF SEASONAL ALLERGIC RHINITIS BY NASALY ADMINISTERING A COMBINATION OF OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,064,442
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3043773 | ⤷ Subscribe | CA 2021 00050 | Denmark | ⤷ Subscribe |
| European Patent Office | 3043773 | ⤷ Subscribe | 301154 | Netherlands | ⤷ Subscribe |
| European Patent Office | 3043773 | ⤷ Subscribe | 122021000085 | Germany | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
